Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for MEDP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 752.66M
March 31, 2026 739.18M
December 31, 2025 713.22M
September 30, 2025 711.24M
June 30, 2025 614.10M
March 31, 2025 581.97M
December 31, 2024 608.82M
September 30, 2024 574.54M
June 30, 2024 539.85M
March 31, 2024 505.98M
December 31, 2023 433.37M
September 30, 2023 413.66M
June 30, 2023 407.77M
March 31, 2023 421.87M
December 31, 2022 388.05M
September 30, 2022 322.26M
June 30, 2022 286.12M
March 31, 2022 252.26M
December 31, 2021 263.33M
September 30, 2021 297.93M
June 30, 2021 285.34M
March 31, 2021 266.85M
Date Value
December 31, 2020 258.68M
September 30, 2020 210.12M
June 30, 2020 214.65M
March 31, 2020 217.01M
December 31, 2019 201.87M
September 30, 2019 184.37M
June 30, 2019 172.58M
March 31, 2019 167.29M
December 31, 2018 156.58M
September 30, 2018 145.79M
June 30, 2018 132.29M
March 31, 2018 121.36M
December 31, 2017 97.38M
September 30, 2017 97.80M
June 30, 2017 100.97M
March 31, 2017 78.43M
December 31, 2016 91.73M
September 30, 2016 89.90M
June 30, 2016 79.50M
March 31, 2016 98.50M
December 31, 2015 85.87M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
IQVIA Holdings, Inc. 2.819B
Charles River Laboratories International, Inc. 582.15M
Avantor, Inc. 597.00M
Champions Oncology, Inc. -4.472M
Personalis, Inc. -92.30M